These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64 related articles for article (PubMed ID: 3964272)
1. GTP influences the binding of vincristine in human tumor cytosols. Bowman LC; Houghton JA; Houghton PJ Biochem Biophys Res Commun; 1986 Mar; 135(3):695-700. PubMed ID: 3964272 [TBL] [Abstract][Full Text] [Related]
2. Influence of guanine nucleotides on vincristine binding in tumor cytosols and purified tubulin: evidence for an inhibitor of vincristine binding. Bowman LC; Houghton JA; Houghton PJ J Cell Physiol; 1990 Sep; 144(3):376-82. PubMed ID: 2391373 [TBL] [Abstract][Full Text] [Related]
3. Formation and stability of vincristine-tubulin complex in kidney cytosols. Role of GTP and GTP hydrolysis. Bowman LC; Houghton JA; Houghton PJ Biochem Pharmacol; 1988 Apr; 37(7):1251-7. PubMed ID: 3355599 [TBL] [Abstract][Full Text] [Related]
4. Stability of vincristine complexes in cytosols derived from xenografts of human rhabdomyosarcoma and normal tissues of the mouse. Houghton JA; Williams LG; Houghton PJ Cancer Res; 1985 Aug; 45(8):3761-7. PubMed ID: 2990677 [TBL] [Abstract][Full Text] [Related]
5. Relationship between binding affinity, retention and sensitivity of human rhabdomyosarcoma xenografts to Vinca alkaloids. Houghton JA; Williams LG; Dodge RK; George SL; Hazelton BJ; Houghton PJ Biochem Pharmacol; 1987 Jan; 36(1):81-8. PubMed ID: 3541941 [TBL] [Abstract][Full Text] [Related]
6. In situ selection of a human rhabdomyosarcoma resistant to vincristine with altered beta-tubulins. Houghton JA; Houghton PJ; Hazelton BJ; Douglass EC Cancer Res; 1985 Jun; 45(6):2706-12. PubMed ID: 3986804 [TBL] [Abstract][Full Text] [Related]
7. Determinants of intrinsic sensitivity to Vinca alkaloids in xenografts of pediatric rhabdomyosarcomas. Houghton JA; Williams LG; Torrance PM; Houghton PJ Cancer Res; 1984 Feb; 44(2):582-90. PubMed ID: 6692363 [TBL] [Abstract][Full Text] [Related]
8. Altered molecular properties of tubulin in a multidrug-resistant variant of Chinese hamster cells selected for resistance to vinca alkaloids. Pain J; Sirotnak FM; Barrueco JR; Yang CH; Biedler JL J Cell Physiol; 1988 Aug; 136(2):341-7. PubMed ID: 3045133 [TBL] [Abstract][Full Text] [Related]
9. Modulation by verapamil of vincristine pharmacokinetics and toxicity in mice bearing human tumor xenografts. Horton JK; Thimmaiah KN; Houghton JA; Horowitz ME; Houghton PJ Biochem Pharmacol; 1989 Jun; 38(11):1727-36. PubMed ID: 2735930 [TBL] [Abstract][Full Text] [Related]
10. Markedly decreased binding of vincristine to tubulin in vinca alkaloid-resistant Chinese hamster cells is associated with selective overexpression of alpha and beta tubulin isoforms. Sirotnak FM; Danenberg KD; Chen J; Fritz F; Danenberg PV Biochem Biophys Res Commun; 2000 Mar; 269(1):21-4. PubMed ID: 10694470 [TBL] [Abstract][Full Text] [Related]
11. Interaction of vinca alkaloids with tubulin: a comparison of vinblastine, vincristine, and vinorelbine. Lobert S; Vulevic B; Correia JJ Biochemistry; 1996 May; 35(21):6806-14. PubMed ID: 8639632 [TBL] [Abstract][Full Text] [Related]
12. Therapeutic selectivity of vinca alkaloids: a role for guanosine 5'-triphosphate? Houghton PJ; Houghton JA; Bowman LC; Hazelton BJ Anticancer Drug Des; 1987 Oct; 2(2):165-79. PubMed ID: 3329524 [TBL] [Abstract][Full Text] [Related]
13. Correlates of vincristine resistance in four murine tumor cell lines. Bender RA; Kornreich WD; Wodinsky I Cancer Lett; 1982; 15(3):335-41. PubMed ID: 7116335 [TBL] [Abstract][Full Text] [Related]
14. Relationships between tumor responsiveness, vincristine pharmacokinetics and arrest of mitosis in human tumor xenografts. Horton JK; Houghton PJ; Houghton JA Biochem Pharmacol; 1988 Oct; 37(20):3995-4000. PubMed ID: 3190743 [TBL] [Abstract][Full Text] [Related]
15. Scheduling of vincristine: drug accumulation and response of xenografts of childhood rhabdomyosarcoma determined by frequency of administration. Houghton JA; Meyer WH; Houghton PJ Cancer Treat Rep; 1987; 71(7-8):717-21. PubMed ID: 3607783 [TBL] [Abstract][Full Text] [Related]
16. Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. Tsuruo T; Iida H; Tsukagoshi S; Sakurai Y Cancer Res; 1981 May; 41(5):1967-72. PubMed ID: 7214365 [TBL] [Abstract][Full Text] [Related]
17. Characteristics of vincristine resistance in vincristine resistant human myelogenous leukemia K562. Tsuruo T; Oh-Hara T; Saito H Anticancer Res; 1986; 6(4):637-41. PubMed ID: 3463241 [TBL] [Abstract][Full Text] [Related]
18. Characterization of the interaction of TZT-1027, a potent antitumor agent, with tubulin. Natsume T; Watanabe J; Tamaoki S; Fujio N; Miyasaka K; Kobayashi M Jpn J Cancer Res; 2000 Jul; 91(7):737-47. PubMed ID: 10920282 [TBL] [Abstract][Full Text] [Related]
19. Promotion by verapamil of vincristine responsiveness in tumor cell lines inherently resistant to the drug. Tsuruo T; Iida H; Naganuma K; Tsukagoshi S; Sakurai Y Cancer Res; 1983 Feb; 43(2):808-13. PubMed ID: 6848194 [TBL] [Abstract][Full Text] [Related]
20. Reciprocal cross-resistance in human rhabdomyosarcomas selected in vivo for primary resistance to vincristine and L-phenylalanine mustard. Horton JK; Houghton PJ; Houghton JA Cancer Res; 1987 Dec; 47(23):6288-93. PubMed ID: 2890432 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]